Work

Abstract 16914: On-treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF

Year: 2015

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.132.suppl_3.16914

Authors: Christopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, Samuel M Lindner, Jonathan P Piccini, Richard C Becker, Scott D Berkowitz, Guenter Breithardt, Keith A Fox, Jonathan L Halperin, Graeme J Hankey, Kenneth W Mahaffey, Christopher C Nessel, Daniel E Singer, Manesh R Patel

Institutions: Duke University, University of Cincinnati, Bayer (United States), University of Münster, University of Edinburgh, Mount Sinai Hospital, The University of Western Australia, Stanford University, Janssen Research & Development (United States), Harvard University, Massachusetts General Hospital

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2581510606

Cites:

Cited by:

Related to: 10